CIC-1 chloride channels: State-of-the-art research and future challenges

Frontiers in Cellular Neuroscience

Volumn 9, Issue APR, 2015, Pages

  Imbrici, Paola ^a   Altamura, Concetta ^a   Pessia, Mauro ^b   Mantegazza, Renato ^c   Desaphy, Jean François ^a   Camerino, Diana Conte ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c IRCCS   (Italy)

Author keywords

ClC 1 chloride channel; Ion channel pharmacology; Myotonia congenita; Skeletal muscle physiology; Skeletal muscle plasticity

Indexed keywords

4 CHLOROPHENOXYACETIC ACID; ACETAZOLAMIDE; ADENOSINE TRIPHOSPHATE; ANGIOTENSIN II; CALCIUM; CHLORIDE CHANNEL; CLC 1 CHLORIDE CHANNEL; CLOFIBRATE; FENOFIBRATE; GHRELIN; GROWTH HORMONE; GROWTH HORMONE SECRETAGOGUE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE; NIFLUMIC ACID; POTASSIUM; PROTEIN KINASE C; SODIUM; SOMATOMEDIN C; TAURINE; UNCLASSIFIED DRUG; VOLTAGE GATED CHLORIDE CHANNEL;

AGING; ARTICLE; BECKER MUSCULAR DYSTROPHY; CHEMICAL STRUCTURE; ELECTROPHYSIOLOGY; EPILEPSY; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; MEDICAL RESEARCH; MUSCLE RIGIDITY; MYOTONIC DYSTROPHY; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NEUROMUSCULAR FUNCTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; THOMSEN DISEASE; TORPEDO MARMORATA;

EID: 84929600945     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00156     Document Type: Article

References (177)

1. Accardi, A., Ferrera, L., and Pusch, M. (2001). Drastic reduction of the slow gate of human muscle chloride channel (ClC-1) by mutation C277S. J. Physiol. 534, 745-752.doi: 10.1111/j.1469-7793.2001.00745.x
2. Accardi, A., Lobet, S., Williams, C., Miller, C., and Dutzler, R. (2006). Synergism between halide binding and proton transport in a CLC-type exchanger. J. Mol. Biol. 362, 691-699.doi: 10.1016/j.jmb.2006.07.081
3. Accardi, A., and Pusch, M. (2000). Fast and slow gating relaxations in the muscle chloride channel ClC-1. J. Gen. Physiol. 116, 433-444.doi: 10.1085/jgp.116.3.433
4. Accardi, A., and Pusch, M. (2003). Conformational changes in the pore of CLC-0. J. Gen. Physiol. 122, 277-293.doi: 10.1085/jgp.200308834
5. Adrian, R. H., and Bryant, S. H. (1974). On the repetitive discharge in myotonic muscle fibres. J. Physiol. 240, 505-515.doi: 10.1113/jphysiol.1974.sp010620
6. Ardissone, A., Bragato, C., Caffi, L., Blasevich, F., Maestrini, S., Bianchi, M. L., et al. (2013). Novel PTRF mutation in a child with mild myopathy and very mild congenital lipodystrophy. BMC Med. Genet. 14:89.doi: 10.1186/1471-2350-14-89
7. Aromataris, E. C., Astill, D. S., Rychkov, G. Y., Bryant, S. H., Bretag, A. H., and Roberts, M. L. (1999). Modulation of the gating of CIC-1 by S-(-) 2-(4-chlorophenoxy) propionic acid. Br. J. Pharmacol. 126, 1375-1382.doi: 10.1038/sj.bjp.0702459
8. Basu, A., Nishanth, P., and Ifaturoti, O. (2009). Pregnancy in women with myotonia congenita. Int. J. Gynaecol. Obstet. 106, 62-63.doi: 10.1016/j.ijgo.2009.01.031
9. Bennetts, B., and Parker, M. W. (2013). Molecular determinants of common gating of a ClC chloride channel. Nat. Commun. 4, 2507.doi: 10.1038/ncomms3507
10. Bennetts, B., Parker, M. W., and Cromer, B. A. (2007). Inhibition of skeletal muscle ClC-1 chloride channels by low intracellular pH and ATP. J. Biol. Chem. 282, 32780-32791.doi: 10.1074/jbc.M703259200
11. Bennetts, B., Yu, Y., Chen, T. Y., and Parker, M. W. (2012). Intracellular β-nicotinamide adenine dinucleotide inhibits the skeletal muscle ClC-1 chloride channel. J. Biol. Chem. 287, 25808-25820.doi: 10.1074/jbc.M111.327551
12. Borges, A. S., Barbosa, J. D., Resende, L. A. L., Mota, L. S. L. S., Amorim, R. M., Carvalho, T. L., et al. (2013). Clinical and molecular study of a new form of hereditary myotonia in Murrah water buffalo. Neuromuscul. Disord. 23, 206-213.doi: 10.1016/j.nmd.2012.11.008
13. Bretag, A. H. (1987). Muscle chloride channels. Physiol. Rev. 67, 618-724.
14. Bretag, A. H., Dawe, S. R., Kerr, D. I., and Moskwa, A. G. (1980). Myotonia as a side effect of diuretic action. Br. J. Pharmacol. 71, 467-471.doi: 10.1111/j.1476-5381.1980.tb10959.x
15. Brinkmeier, H., and Jockusch, H. (1987). Activators of protein kinase C induce myotonia by lowering chloride conductance in muscle. Biochem. Biophys. Res. Comm. 148, 1383-1389.doi: 10.1016/S0006-291X(87)80285-1
16. Brugnoni, R., Galantini, S., Confalonieri, P., Balestrini, M. R., Cornelio, F., and Mantegazza, R. (1999). Identification of three novel mutations in the major human skeletal muscle chloride channel gene (CLCN1), causing myotonia congenita. Hum. Mutat. 14, 447.doi: 10.1002/(SICI)1098-1004(199911)14:5<447::AID-HUMU13>3.0.CO;2-Z
17. Brugnoni, R., Kapetis, D., Imbrici, P., Pessia, M., Canioni, E., Colleoni, L., et al. (2013). A large cohort of myotonia congenita probands: novel mutations and a high-frequency mutation region in exons 4 and 5 of the CLCN1 gene. J. Hum. Genet. 58, 581-587.doi: 10.1038/jhg.2013.58
18. Bryant, S. H. (1969). Cable properties of external intercostal muscle fibres from myotonic and nonmyotonic goats. Muscle membrane of normal and myotonic goats in normal and low external chloride. J. Physiol. 204, 539-550.doi: 10.1113/jphysiol.1969.sp008930
19. Bryant, S. H., and Conte-Camerino, D. (1991). Chloride channel regulation in the skeletal muscle of normal and myotonic goats. Pflugers. Arch. 417, 605-610.doi: 10.1007/BF00372958
20. Bryant, S. H., and Morales-Aguilera, A. (1971). Chloride conductance in normal and myotonic muscle fibres and the action of monocarboxylic aromatic acids. J. Physiol. 219, 367-383.doi: 10.1113/jphysiol.1971.sp009667
21. Burge, J. A., and Hanna, M. G. (2012). Novel insights into the pathomechanisms of skeletal muscle channelopathies. Curr. Neurol. Neurosci. Rep. 12, 62-69.doi: 10.1007/s11910-011-0238-3
22. Bykova, E. A., Zhang, X. D., Chen, T. Y., and Zheng, J. (2006). Large movement in the C terminus of CLC-0 chloride channel during slow gating. Nat. Struct. Mol. Biol. 13, 1115-1119.doi: 10.1038/nsmb1176
23. Camerino, G. M., Bouchè, M., De Bellis, M., Cannone, M., Liantonio, A., Musaraj, K., et al. (2014). Protein kinase C theta (PKCθ) modulates the ClC-1 chloride channel activity and skeletal muscle phenotype: a biophysical and gene expression study in mouse models lacking the PKCθ. Pflugers. Arch. 466, 2215-28.doi: 10.1007/s00424-014-1495-1.
24. Cardani, R., Giagnacovo, M., Botta, A., Rinaldi, F., Morgante, A., Udd, B., et al. (2012). Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2. J. Neurol. 259, 2090-2099.doi: 10.1007/s00415-012-6462-1.
25. Cederholm, J. M., Rychkov, G. Y., Bagley, C. J., and Bretag, A. H. (2010). Inter-subunit communication and fast gate integrity are important for common gating in hClC-1. Int. J. Biochem. Cell Biol. 42, 1182-1188.doi: 10.1016/j.biocel.2010.04.004
26. Charlet BN., Savkur, R. S., Singh, G., Philips, A. V., Grice, E. A., and Cooper, T. A. (2002). Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell 10, 45-53.doi: 10.1016/S1097-2765(02)00572-5
27. Chen, T. T., Klassen, T. L., Goldman, A. M., Marini, C., Guerrini, R., and Noebels, J. L. (2013). Novel brain expression of ClC-1 chloride channels and enrichment of CLCN1 variants in epilepsy. Neurology 80, 1078-1085.doi: 10.1212/WNL.0b013e31828868e7
28. Chen, W., Wang, Y., Abe, Y., Cheney, L., Udd, B., and Li, Y. P. (2007). Haploinsufficiency for Znf9 in Znf9+/-mice is associated with multiorgan abnormalities resembling myotonic dystrophy. J. Mol. Biol. 368, 8-17.doi: 10.1016/j.jmb.2007.01.088
29. Colding-Jørgensen, E. (2005). Phenotypic variability in myotonia congenita. Muscle Nerve 32, 19-34.doi: 10.1002/mus.20295
30. Conte Camerino, D., De Luca, A., Mambrini, M., and Vrbovà, G. (1989). Membrane ionic conductances in normal and denervated skeletal muscle of the rat during development. Pflugers. Arch. 413, 568-570.doi: 10.1007/ BF00594192
31. Conte-Camerino, D., Mambrini, M., De Luca, A., Tricarico, D., Bryant, S. H., Tortorella, V., et al. (1988). Enantiomers of clofibric acid analogs have oppositeactions on rat skeletal muscle chloride channels. Pflugers. Arch. 413, 105-107.doi: 10.1007/BF00581238
32. Cozzoli, A., Liantonio, A., Conte, E., Cannone, M., Massari, A. M., Giustino, A., et al. (2014). Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase. Am. J. Physiol. Cell Physiol. 307, C634-C647.doi: 10.1152/ajpcell.00372.2013
33. D’Adamo, M. C., Catacuzzeno, L., Di Giovanni, G., Franciolini, F., and Pessia, M. (2013). K+ Channelepsy: progress in the neurobiology of potassium channels and epilepsy. Front. Cell. Neurosci. 7:134.doi: 10.3389/fncel.2013.00134
34. D’Adamo, M. C., Di Giovanni, G., and Pessia, M. (2014). "Animal models of episodic ataxia type 1 (EA1)," in Movement Disorders: Genetics and Models, 2nd Edn, eds Mark and S. LeDoux, (San Diego, CA: Academic Press Inc./Elsevier Science Publishing Co. Inc.), 797-807.
35. D’Adamo, M. C., Gallenmüller, C., Servettini, I., Hartl, E., Tucker, S. J., Arning, L., et al. (2015). Hyperthermia, short-sleep phenotype and severe migraine associated with episodic ataxia type 1. Front. Physiol. 5:525.doi: 10.3389/fphys.2014.00525
36. D’Adamo, M. C., Hanna, M. G., Di Giovanni, G., and Pessia, M. (2012). "Episodic Ataxia Type 1," in GeneReviews [Internet], eds R. A. Pagon, T. C. Bird, C. R. Dolan, and K. Stephens (Seattle, WA: University of Washington).
37. D’Adamo, M. C., Imbrici, P., Sponcichetti, F., and Pessia, M. (1999). Mutations in the KCNA1 gene associated with episodic ataxia type-1 syndrome impair heteromeric voltage-gated K+ channel function. FASEB J. 13, 1335-1345.
38. de Diego, C., Gámez, J., Plassart-Schiess, E., Lasa, A., Del Río, E., Cervera, C., et al. (1999). Novel mutations in the muscle chloride channel CLCN1 gene causing myotonia congenita in Spanish families. J. Neurol. 246, 825-829.doi: 10.1007/s004150050462
39. De Luca, A., Conte Camerino, D., Connold, A., and Vrbovà, G. (1990a). Pharmacological block of chloride channels of developing rat skeletal muscle affects the differentiation of specific contractile properties. Pflugers. Arch. 416, 17-21.doi: 10.1007/BF00370216
40. De Luca, A., Mambrini, M., and Conte Camerino, D. (1990b). Changes in membrane ionic conductances and excitability characteristics of rat skeletal muscle during aging. Pflugers Arch. 415, 642-644.doi: 10.1007/BF02583519
41. De Luca, A., and Conte Camerino, D. (1992). Effects of aging on the mechanical threshold of rat skeletal muscle fibers. Pflugers Arch. 420, 407-409.doi: 10.1007/BF00374477
42. De Luca, A., Pierno, S., and Camerino, D. C. (1995). Changes of membrane electrical properties in extensor digitorum longus muscle from dystrophic (mdx) mice. Muscle Nerve 18, 1196-1198.doi: 10.1002/mus.880181016
43. De Luca, A., Pierno, S., and Camerino, D. C. (1996). Effect of taurine depletion on excitation-contraction coupling and Cl-conductance of rat skeletal muscle. Eur. J. Pharmacol. 296, 215-222.doi: 10.1016/0014-2999(95)00702-4
44. De Luca, A., Pierno, S., Cocchi, D., and Conte Camerino, D. (1997a). Effects of chronic growth hormone treatment in aged rats on the biophysical and pharmacological properties of skeletal muscle chloride channels. Br. J. Pharmacol. 121, 369-374.doi: 10.1038/sj.bjp.0701129
45. De Luca, A., Pierno, S., and Camerino, D. C. (1997b). Electrical properties of diaphragm and EDL muscles during the life of dystrophic mice. Am. J. Physiol. 272, C333-C340.
46. De Luca, A., Pierno, S., Liantonio, A., Camerino, C., and Conte Camerino, D. (1998). Phosphorylation and IGF-1-mediated dephosphorylation pathways control the activity and the pharmacological properties of skeletal muscle chloride channels. Br. J. Pharmacol. 125, 477-482.doi: 10.1038/sj.bjp.0702107
47. De Luca, A., Tricarico, D., Pierno, S., and Conte Camerino, D. (1994a). Aging and chloride channel regulation in rat fast-twitch muscle fibres. Pflugers. Arch. 427, 80-85.doi: 10.1007/BF00585945
48. De Luca, A., Pierno, S., Cocchi, D., and Conte Camerino, D. (1994b). Growth hormone administration to aged rats improves membrane electrical properties of skeletal muscle fibers. J. Pharmacol. Exp. Ther. 269, 948-953.
49. De Luca, A., Tricarico, D., Wagner, R., Bryant, S. H., Tortorella, V., and Conte Camerino, D. (1992). Opposite effects of enantiomers of clofibric acid derivative on rat skeletal muscle chlorideconductance: antagonism studies and theoretical modeling of two different receptor site interactions. J. Pharmacol. Exp. Ther. 260, 364-368.
50. de Paoli, F. V., Broch-Lips, M., Pedersen, T. H., and Nielsen, O. B. (2013). Relationship between membrane Cl-conductance and contractile endurance in isolated rat muscles. J. Physiol. 591, 531-545.doi: 10.1113/jphysiol.2012.243246
51. de Paoli, F. V., Ørtenblad, N., Pedersen, T. H., Jørgensen, R., and Nielsen, O. B. (2010). Lactate per se improves the excitability of depolarized rat skeletal muscle by reducing the Cl-conductance. J. Physiol.588, 4785-4794.doi: 10.1113/jphysiol.2010.196568.
52. Delbono, O., O’Rourke, K. S., and Ettinger, W. H. (1995). Excitation-calcium release uncoupling in aged single human skeletal muscle fibers. J. Membr. Biol. 148, 211-222.doi: 10.1007/BF00235039
53. Desaphy, J.-F., Carbonara, R., Costanza, T., and Conte Camerino, D. (2014). Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses new promising antimyotonic drugs. Exp. Neurol. 255, 96-102.doi: 10.1016/j.expneurol.2014.02.023
54. Desaphy, J.-F., De Luca, A., Pierno, S., Imbrici, P., and Conte Camerino, D. (1998). Partial recovery of skeletal muscle sodium channel properties in aged rats chronically treated with growth hormone or the GH-secretagogue hexarelin. J. Pharmacol. Exp. Ther. 286, 903-912.
55. Desaphy, J.-F., Gramegna, G., Altamura, C., Dinardo, MM., Imbrici, P., George, A. L. Jr., et al. (2013). Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenita presenting with different clinical phenotypes. Exp. Neurol. 248, 530-540.doi: 10.1016/j.expneurol.2013.07.018
56. DiFranco, M., Herrera, A., and Vergara, J. L. (2011). Chloride currents from the transverse tubular system in adult mammalian skeletal muscle fibers. J. Gen. Physiol. 137, 21-41.doi: 10.1085/jgp.201010496
57. Duffield, M., Rychkov, G., Bretag, A., and Roberts, M. (2003). Involvement of helices at the dimmer interface in ClC-1 common gating. J. Gen. Physiol. 121, 149-161.doi: 10.1085/jgp.20028741
58. Duffield, M. D., Rychkov, G. Y., Bretag, A. H., and Roberts, M. L. (2005). Zinc inhibits human ClC-1 muscle chloride channel by interacting with its common gating mechanism. J. Physiol. 568, 5-12.doi: 10.1113/jphysiol.2005.091777
59. Duno, M., Colding-Jorgensen, E., Grunnet, M., Jespersen, T., Vissing, J., and Schwartz, M. (2004). Difference in allelic expression of the CLCN1 gene and the possible influence on the myotonia congenita phenotype. Eur. J. Hum. Genet. 12, 738-743.doi: 10.1038/sj.ejhg.5201218
60. Dutka, T. L., Murphy, R. M., Stephenson, D. G., and Lamb, G. D. (2008). Chloride conductance in the transverse tubular system of rat skeletal muscle fibres: importance in excitation-contraction coupling and fatigue. J. Physiol. 586.3, 875-887.doi: 10.1113/jphysiol.2007.144667
61. Dutzler, R. (2006). The ClC family of chloride channels and transporters. Curr. Opin. Struct. Biol. 16, 439-446.doi: 10.1016/j.sbi.2006.06.002
62. Dutzler, R., Campbell, E. B., Cadene, M., Chait, B. T., and MacKinnon, R. (2002). X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity. Nature 415, 287-294.doi: 10.1038/415287a
63. Dutzler, R., Campbell, E. B., and MacKinnon, R. (2003). Gating the selectivity filter in ClC chloride channels. Science 300, 108-112.doi: 10.1126/science.10 82708
64. Eguchi, H., Tsujino, A., Kaibara, M., Hayashi, H., Shirabe, S., Taniyama, K., et al. (2006). Acetazolamide acts directly on the human skeletal muscle chloride channel. Muscle Nerve 34, 292-297.doi: 10.1002/mus.20585
65. Esteban, J., Neumeyer, A. M., McKenna-Yasek, D., and Brown, R. H. (1998). Identification of two mutations and a polymorphism in the chloride channel CLCN-1 in patients with Becker’s generalized myotonia. Neurogenetics 1, 185-188.doi: 10.1007/s100480050027
66. Estévez, R., Pusch, M., Ferrer-Costa, C., Orozco, M., and Jentsch, T. J. (2004). Functional and structural conservation of CBS domains from CLC chloride channels. J. Physiol. 557, 363-378.doi: 10.1113/jphysiol.2003. 058453
67. Estévez, R., Schroeder, B. C., Accardi, A., Jentsch, T. J., and Pusch, M. (2003). Conservation of chloride channel structure revealed by an inhibitor binding site in ClC-1. Neuron 38, 47-59.doi: 10.1016/S0896-6273(03)00168-5
68. Feng, L., Campbell, E. B., Hsiung, Y., and MacKinnon, R. (2010). Structure of a eukaryotic CLC transporter defines an intermediate state in the transport cycle. Science 330, 635-641.doi: 10.1126/science.1195230
69. Fialho, D., Schorge, S., Pucovska, U., Davies, N. P., Labrum, R., Haworth, A., et al. (2007). Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions. Brain 130, 3265-3274.doi: 10.1093/brain/awm248
70. Fraser, J. A., Huang, C. L., and Pedersen, T. H. (2011). Relationships between resting conductances, excitability, and t-system ionic homeostasis in skeletal muscle. J. Gen. Physiol. 138, 95-116.doi: 10.1085/jgp.201110617
71. Fraysse, B., Desaphy, J.-F., Rolland J.-F., Pierno, S., Liantonio, A., Giannuzzi, V., et al. (2006). Fiber type-related changes in rat skeletal muscle calcium homeostasis during aging and restoration by growth hormone. Neurobiol. Dis. 21, 372-380.doi: 10.1016/j.nbd.2005.07.012
72. Gandolfi, B., Daniel, R. J., O’Brien, D. P., Guo, L. T., Youngs, M. D., Leach, S. B., et al. (2014). A novel mutation in CLCN1 associated with feline myotonia congenita. PLoS ONE 9:e109926.doi: 10.1371/journal.pone.0109926
73. Garcia-Olivares, J., Alekov, A., Boroumand, M. R., Begemann, B., Hidalgo, P., and Fahlke, C. (2008). Gating of human ClC-2 chloride channels and regulation by carboxy-terminal domains. J. Physiol. 586, 5325-5336.doi: 10.1113/jphysiol.2008.158097
74. George, A. L. Jr., Crackower, M. A., Abdalla, J. A., Hudson, A. J., and Ebers, G. C. (1993). Molecular basis of Thomsen’s disease (autosomal dominant myotonia congenita) Nat. Genet. 3, 305-310.doi: 10.1038/ng0493-305
75. Goblet, C., and Whalen, R. G. (1995). Modifications ofgene expressionin myotonic murine skeletal muscle are associated with abnormal expression of myogenic regulatory factors. Dev. Biol. 170, 262-273.doi: 10.1006/dbio.1995.1213
76. Griggs, R. C., Moxley, R. T. III, Riggs, J. E., and Engel, W. K. (1978). Effects of aceta-zolamide on myotonia. Ann. Neurol. 3, 531-537.doi: 10.1002/ana.410030614
77. Guzman, R. E., Grieschat, M., Fahlke, C., and Alekov, A. K. (2013). ClC-3 is an intracellular chloride/proton exchanger with large voltage-dependent nonlinear capacitance. ACS Chem. Neurosci. 4, 994-1003.doi: 10.1021/cn400032z
78. Hao, M., Akrami, K., Wei, K., De Diego, C., Che, N., Ku, J. H., et al. (2008). Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy. Dev. Dyn. 237, 403-410.doi: 10.1002/dvdy.21428
79. Hille, B. (1992). Axons, ions, and dons. Science 258, 144-145.doi: 10.1126/science.258.5079.144
80. Hodgkin, A. L., and Horowicz, P. (1959). The influence of potassium and chloride ions on the membrane potential of single muscle fibres. J. Physiol. 148, 127-160.doi: 10.1113/jphysiol.1959.sp006278
81. Hsiao, K. M., Huang, R. Y., Tang, P. H., and Lin, M. J. (2010). Functional study of CLC-1 mutants expressed in Xenopus ocytes reveals that a C-terminal region Thr891-Ser892-Thr893 is responsible for the effects of protein kinase C activator. Cell. Physiol. Biochem. 25, 687-694.doi: 10.1159/000315088
82. Imbrici, P., Gualandi, F., D’Adamo, M. C., Taddei Masieri, M., Cudia, P., De Grandis, D., et al. (2008). A Novel KCNA1 mutation identified in an Italian family affected by episodic ataxia type 1. Neuroscience 157, 577-587.doi: 10.1016/j.neuroscience.2008.09.022
83. Jayaram, H., Robertson, J. L., Wu, F., Williams, C., and Miller, C. (2011). Structure of a slow CLC Cl-/H+ antiporter from a cyanobacterium. Biochemistry 50, 788-794.doi: 10.1021/bi1019258
84. Jentsch, T. J. (2015). Discovery of CLC transport proteins: cloning, structure, function and pathophysiology. J. Physiol.doi: 10.1113/JP270043 [Epub ahead ofprint].
85. Jentsch, T. J., Friedrich, T., Schriever, A., and Yamada, H. (1999). The CLCchloride channel family. Pflugers. Arch. 437, 783-795.doi: 10.1007/s004240050847
86. Jentsch, T. J., Steinmeyer, K., and Schwarz, G. (1990). Primary structure of Torpedo marmorata chloride channel isolated by expression cloning in Xenopus ocytes. Nature 348, 510-514.doi: 10.1038/348510a0
87. Koch, M. C., Steinmeyer, K., Lorenz, C., Ricker, K., Wolf, F., Otto, M., et al. (1992). The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 257, 797-800.doi: 10.1126/science.1379744
88. Lacy, B. E., and Levy, L. C. (2007). Lubiprostone: a chloride channel activator. J. Clin. Gastroenterol. 41, 345-351.doi: 10.1097/01.mcg.0000225665.68920.df
89. Lamb, G. D., Murphy, R. M., and Stephenson, D. G. (2011). On the localization of ClC-1 in skeletal muscle fibers. J. Gen. Physiol. 137, 327-329.doi: 10.1085/jgp.201010580
90. Leisle, L., Ludwig, C. F., Wagner, F. A., Jentsch, T. J., and Stauber, T. (2011). ClC-7 is a slowly voltage-gated 2Cl(-)/1H(+)-exchanger and requires Ostm1 for transport activity. EMBO J. 30, 2140-2152.doi: 10.1038/emboj.2011.137
91. Liantonio, A., Accardi, A., Carbonara, G., Fracchiolla, G., Loiodice, F., Tortorella, P., et al. (2002). Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid. Mol. Pharmacol. 62, 265-271.doi: 10.1124/mol.62.2.265
92. Liantonio, A., Giannuzzi, V., Picollo, A., Babini, E., Pusch, M., and Conte Camerino, D. (2007). Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium. Br. J. Pharmacol. 150, 235-247.doi: 10.1038/sj.bjp.0706954
93. Licchetta, L., Bisulli, F., Naldi, I., Mainieri, G., and Tinuper, P. (2014). Limbic encephalitis with anti-GAD antibodies and Thomsen myotonia: a casual or causal association? Epileptic Disord. 16, 362-365.doi: 10.1684/epd.2014.0668
94. Lim, H.-H., Shane, T., and Miller, C. (2012). Intracellular proton access in a Cl-/H+ antiporter. PLoS Biol. 10:e1001441.doi: 10.1371/journal.pbio.1001441
95. Lo Monaco, M., D’Amico, A., Luigetti, M., Desaphy, J.-F., and Modoni, A. (2015). Effect of mexiletine on transitory depression of compound motor action potential in recessive myotonia congenita. Clin. Neurophysiol. 126, 399-403.doi: 10.1016/j.clinph.2014.06.008
96. Lobet, S., and Dutzler, R. (2006). Ion-binding properties of the ClC chloride selectivity filter. EMBO J. 25, 24-33.doi: 10.1038/sj.emboj.7600909
97. Logigian, E. L., Martens, W. B., Moxley R. T. IV, McDermott, M. P., Dilek, N., Wiegner, A. W., et al. (2010). Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1. Neurology 74, 1441-1448.doi: 10.1212/WNL.0b013e3181dc1a3a
98. Lorenz, C., Pusch, M., and Jentsch, T. J. (1996). Heteromultimeric CLC chloride channels with novel properties. Proc. Natl. Acad. Sci. U.S.A. 93, 13362-13366.doi: 10.1073/pnas.93.23.13362
99. Lossin, C., and George, A. L. Jr. (2008). Myotonia congenita. Adv. Genet. 63, 25-55.doi: 10.1016/S0065-2660(08)01002-X
100. Lucchiari, S., Ulzi, G., Magri, F., Bucchia, M., Corbetta, F., Servida, M., et al. (2013). Clinical evaluation and cellular electrophysiology of a recessive CLCN1 patient. J. Physiol. Pharmacol. 64, 669-678.
101. Lueck, J. D., Lungu, C., Mankodi, A., Osborne, R. J., Welle, S. L., Dirksen, R. T., et al. (2007). Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1. Am. J. Physiol. Cell Physiol. 292, C1291-C2917.doi: 10.1152/ajpcell.00336.2006
102. Lueck, J. D., Rossi, A. E., Thornton, C. A., Campbell, K. P., and Dirksen, R. T. (2010). Sarcolemmal-restricted localization of functional ClC-1 channels in mouse skeletal muscle. J. Gen. Physiol. 136, 597-613.doi: 10.1085/jgp.201010526
103. Ma, L., Rychkov, G. Y., Bykova, E. A., Zheng, J., and Bretag, A. H. (2011). Movement of hClC-1 C-termini during common gating and limits on their cytoplasmic location. Biochem. J. 436, 415-428.doi: 10.1042/BJ20102153
104. Maduke, M., Miller, C., and Mindell, J. A. (2000). A decade of CLC chloride channels: structure, mechanism, and many unsettled questions. Annu. Rev. Biophys. Biomol. Struct. 29, 411-438.doi: 10.1146/annurev.biophys.29.1.411
105. Mankodi, A., Takahashi, M. P., Jiang, H., Beck, C. L., Bowers, W. J., Moxley, R. T., et al. (2002). Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 10, 35-44.doi: 10.1016/S1097-2765(02)00563-4
106. Markhorst, J. M., Stunnenberg, B. C., Ginjaar, I. B., Drost, G., Erasmus, C. E., and Sie, L. T. (2014). Clinical Experience With Long-Term Acetazolamide Treatment in Children With Nondystrophic Myotonias: a three-case report. Pediatr. Neurol. 51, 537-541.doi: 10.1016/j.pediatrneurol.2014.05.027
107. Markovic, S., and Dutzler, R. (2007). The structure of the cytoplasmic domain of the chloride channel ClC-Ka reveals a conserved interaction interface. Structure 15, 715-725.doi: 10.1016/j.str.2007.04.013
108. Matthews, E., Fialho, D., Tan, S. V., Venance, S. L., Cannon, S. C., Sternberg, D., et al. (2010). The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment. Brain 133, 9-22.doi: 10.1093/brain/awp294
109. Mazón, M. J., Barros, F., De la Peña, P., Quesada, J. F., Escudero, A., Cobo, A. M., et al. (2012). Screening for mutations in Spanish families with myotonia. Functional analysis of novel mutations in CLCN1 gene. Neuromuscul. Disord. 22, 231-243.doi: 10.1016/j.nmd.2011.10.013
110. Meola, G. (2013). Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies. Acta Myol. 32, 154-165.
111. Meola, G., and Cardani, R. (2014). Myotonic dystrophies: an update on clinical aspects, genetic, pathology, and molecular pathomechanisms. Biochim. Biophys. Acta 1852, 594-606.doi: 10.1016/j.bbadis.2014.05.019.
112. Meyer, S., and Dutzler, R. (2006). Crystal structure of the cytoplasmic domain of the chloride channel ClC-0. Structure 14, 299-307.doi: 10.1016/j.str.2005.10.008
113. Middleton, R. E., Pheasant, D. J., and Miller, C. (1996). Homodimeric architecture of a ClC-type chloride ion channel. Nature 383, 337-340.doi: 10.1038/383337a0
114. Miller, C. (1982). Open-state substructure of single chloride channels from Torpedo electroplax. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 299, 401-411.doi: 10.1098/rstb.1982.0140
115. Miller, C., and White, M. M. (1984). Dimeric structure of single chloride channels from Torpedo electroplax. Proc. Natl. Acad. Sci. U.S.A. 81, 2772-2775.doi: 10.1073/pnas.81.9.2772
116. Modoni, A., D’Amico, A., Dallapiccola, B., Mereu, M. L., Merlini, L., Pagliarani, S., et al. (2011). Low-rate repetitive nerve stimulation protocol in an Italian cohort of patients affected by recessive myotonia congenita. J. Clin. Neurophysiol. 28, 39-44.doi: 10.1097/WNP.0b013e31820510d7
117. Neagoe, I., Stauber, T., Fidzinski, P., Bergsdorf, E. Y., and Jentsch, T. J. (2010). The late endosomal ClC-6 mediates proton/chloride countertransport in heterologous plasma membrane expression. J. Biol. Chem. 285, 21689-21697.doi: 10.1074/jbc.M110.125971
118. Nielsen, O. B., de Paoli, F., and Overgaard, K. (2001). Protective effects of lactic acid on force production in rat skeletal muscle. J. Physiol. 536, 161-166.doi: 10.1111/j.1469-7793.2001.t01-1-00161.x
119. Papponen, H., Kaisto, T., Myllylä, V. V., Myllylä, R., and Metsikkö, K. (2005). Regulated sarcolemmal localization of the muscle-specific ClC-1 chloride channel. Exp. Neurol. 191, 163-173.doi: 10.1016/j.expneurol.2004.07.018
120. Papponen, H., Nissinen, M., Kaisto, T., Myllylä, V. V., Myllylä, R., and Metsikkö, K. (2008). F413C and A531V but not R894X myotonia congenita mutations cause defective endoplasmic reticulum export of the muscle-specific chloride channel CLC-1. Muscle Nerve 37, 317-325.doi: 10.1002/mus.20922
121. Pedersen, T. H., de Paoli, F. V., Flatman, J. A., and Nielsen, O. B. (2009a). Regulation of ClC-1 and KATP channels in action potential-firing fast-twitch muscle fibers. J. Gen. Physiol. 134, 309-322.doi: 10.1085/jgp.200910290
122. Pedersen, T. H., Macdonald, W. A., de Paoli, F. V., Gurung, I. S., and Nielsen, O. B. (2009b). Comparison of regulated passive membrane conductance in action potential-firing fastand slow-twitch muscle. J. Gen. Physiol. 134, 323-337.doi: 10.1085/jgp.200910291
123. Pedersen, T. H., de Paoli, F., and Nielsen, O. B. (2005). Increased excitability of acidified skeletal muscle: role of chloride conductance. J. Gen. Physiol. 125, 237-246.doi: 10.1085/jgp.200409173
124. Pedersen, T. H., Nielsen, O. B., Lamb, G. D., and Stephenson, D. G. (2004). Intracellular acidosis enhances the excitability of working muscle. Science 305, 1144-1147.doi: 10.1126/science.1101141
125. Picollo, A., and Pusch, M. (2005). Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. Nature 436, 420-423.doi: 10.1038/nature03720
126. Pierno, S., Camerino, G. M., Cippone, V., Rolland, J.-F., Desaphy, J.-F., De Luca, A., et al. (2009). Statins and fenofibrate affect skeletal muscle chloride conductance in rats by differently impairing ClC-1 channel regulation and expression. Br. J. Pharmacol. 156, 1206-1215.doi: 10.1111/j.1476-5381.2008.00079.x
127. Pierno, S., De Luca, A., Beck, C. L., George, A.L. Jr., and Conte Camerino, D. (1999). Aging-associated down-regulation of ClC-1 expression in skeletal muscle: phenotypic-independent relation to the decrease of chloride conductance. FEBS Lett. 449, 12-16.doi: 10.1016/S0014-5793(99)00202-1
128. Pierno, S., De Luca, A., Camerino, C., Huxtable, R. J., and Camerino, D. C. (1998). Chronic administration of taurine to aged rats improves the electrical and contractile properties of skeletal muscle fibers. J. Pharmacol. Exp. Ther. 286, 1183-1190.
129. Pierno, S., De Luca, A., Desaphy, J.-F., Fraysse, B., Liantonio, A., Didonna, M. P., et al. (2003). Growth hormone secretagogues modulate the electrical and contractile properties of rat skeletal muscle through a ghrelin-specific receptor. Br. J. Pharmacol. 139, 575-584.doi: 10.1038/sj.bjp.0705284
130. Pierno, S., Desaphy, J.-F., Liantonio, A., De Bellis, M., Bianco, G., De Luca, A., et al. (2002). Change of chloride ion channel conductance is an early event of slow-to-fast fibre type transition during unloading-induced muscle disuse. Brain 125, 1510-1521.doi: 10.1093/brain/awf162
131. Pierno, S., Desaphy, J.-F., Liantonio, A., De Luca, A., Zarrilli, A., Mastrofrancesco, L., et al. (2007). Disuse of rat muscle in vivo reduces protein kinase C activity controlling the sarcolemma chloride conductance. J. Physiol. 584, 983-995.doi: 10.1113/jphysiol.2007.141358
132. Pierno, S., Didonna, M. P., Cippone, V., De Luca, A., Pisoni, M., Frigeri, A., et al. (2006). Effects of chronic treatment with statins and fenofibrate on rat skeletal muscle: a biochemical, histological and electrophysiological study. Br. J. Pharmacol. 149, 909-919.doi: 10.1038/sj.bjp.0706917
133. Pierno, S., Tricarico, D., Liantonio, A., Mele, A., Digennaro, C., Rolland, J.-F., et al. (2014). An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function. Age (Dordr.) 36, 73-88.doi: 10.1007/s11357-013-9544-9
134. Pusch, M. (2002). Myotonia caused by mutations in the muscle chloride channel gene ClCN1. Hum. Mut. 19, 423-434.doi: 10.1002/humu.10063
135. Pusch, M., Accardi, A., Liantonio, A., Ferrera, L., De Luca, A., Camerino, D. C., et al. (2001). Mechanism of block of single protopores of the Torpedo chloride channel ClC-0 by 2-(p chlorophenoxy)butyric acid (CPB). J. Gen. Physiol. 118, 45-62.doi: 10.1085/jgp.118.1.45
136. Pusch, M., Liantonio, A., Bertorello, L., Accardi, A., De Luca, A., Pierno, S., et al. (2000). Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives. Mol. Pharmacol. 58, 498-507.
137. Pusch, M., Steinmeyer, K., and Jentsch, T. J. (1994). Low single channel conductance of the major skeletal muscle chloride channel, ClC-1. Biophys. J. 66, 149-152.doi: 10.1016/S0006-3495(94)80753-2
138. Raja Rayan, D. L., and Hanna, M. G. (2010). Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis. Curr. Opin. Neurol. 23, 466-476.doi: 10.1097/WCO.0b013e32833cc97e
139. Raja Rayan, D. L., Haworth, A., Sud, R., Matthews, E., Fialho, D., Burge, J., et al. (2012). A new explanation for recessive myotonia congenita: exon deletions and duplications in CLCN1. Neurology 78, 1953-1958.doi: 10.1212/WNL.0b013e318259e19c
140. Raman, L., Yasodhara, P., and Ramaraju, L. A. (1991). Calcium and magnesium in pregnancy. Nutr. Res. 11, 1231-1236.doi: 10.1016/S0271-5317(05)80542-1
141. Renganathan, M., Messi, M. L., and Delbono, O. (1997). Dihydropyridine receptorryanodine receptor uncoupling in aged skeletal muscle. J. Membr. Biol. 157, 247-253.doi: 10.1007/s002329900233
142. Rhodes, T. H., Vite, C. H., Giger, U., Patterson, D. F., Fahlke, C., and George, A. L. Jr. (1999). A missense mutation in canine ClC-1 causes recessive myotonia congenita in the dog. FEBS Lett. 456, 54-58.doi: 10.1016/S0014-5793(99)00926-6
143. Robertson, J. L., Kolmakova-Partensky, L., and Miller, C. (2010). Design, function and structure of a monomeric ClC transporter. Nature 468, 844-847.doi: 10.1038/nature09556
144. Rosenbohm, A., Rüdel, R., and Fahlke, C. (1999). Regulation of the human skeletal muscle chloride channel hClC-1 by protein kinase C. J. Physiol. 514, 677-685.doi: 10.1111/j.1469-7793.1999.677ad.x
145. Rychkov, G. Y., Pusch, M., Astill, D. S., Roberts, M. L., Jentsch, T. J., and Bretag, A. H. (1996). Concentration and pH dependence of skeletal muscle chloride channel ClC-1. J. Physiol. 497, 423-435.doi: 10.1113/jphysiol.1996.sp021778
146. Salviati, G., Biasia, E., Betto, R., and Danieli Betto, D. (1986). Fast to slow transition induced by experimental myotonia in rat EDL muscle. Pflugers. Arch. 406, 266-272.doi: 10.1007/BF00640912
147. Sangiuolo, F., Botta, A., Mesoraca, A., Servidei, S., Merlini, L., Fratta, G., et al. (1998). Identification of five new mutations and three novel polymorphisms in the muscle chloride channel gene (CLCN1) in 20 Italian patients with dominant and recessive myotonia congenita. Hum. Mutat. 11, 331.doi: 10.1002/(SICI)1098-1004(1998)11:4<331::AID-HUMU13>3.0.CO;2-0
148. Saviane, C., Conti, F., and Pusch, M. (1999). The muscle chloride channel ClC-1 has a double-barreled appearance that is differentially affected in dominant and recessive myotonia. J. Gen. Physiol. 113, 457-468.doi: 10.1085/jgp.113.3.457
149. Scheel, O., Zdebik, A. A., Lourdel, S., and Jentsch, T. J. (2005). Voltage-dependent electrogenic chloride/protonexchange by endosomal CLCproteins. Nature 436, 424-427.doi: 10.1038/nature03860
150. Simpson, B. J., Height, T. A., Rychkov, G. Y., Nowak, K. J., Laing, N. G., Hughes, B. P., et al. (2004). Characterization of three myotonia-associated mutations of the CLCN1 chloride channel gene via heterologous expression. Hum. Mutat. 24, 185-191.doi: 10.1002/humu.9260
151. Skálová, D., Zídková, J., Voháňka, S., Mazanec, R., Mušová, Z., Vondráček, P., et al. (2013). CLCN1 mutations in Czech patients with myotonia congenita, in silico analysis of novel and known mutations in the human dimeric skeletal muscle chloride channel. PLoS ONE 8:e82549.doi: 10.1371/journal.pone.0082549. eCollection 2013
152. Skov, M., De Paoli, F. V., Lausten, J., Nielsen, O. B., and Pedersen, T. H. (2015). Extracellular magnesium and calcium reduce myotonia in isolated ClC-1 chloride channel-inhibited human muscle. Muscle Nerve 51, 65-71.doi: 10.1002/mus.24260
153. Skov, M., Riisager, A., Fraser, J. A., Nielsen, O. B., and Pedersen, T. H. (2013). Extracellular magnesium and calcium reduce myotonia in ClC-1 inhibited rat muscle. Neuromuscul. Disord. 23, 489-502.doi: 10.1016/j.nmd.2013.03.009
154. Statland, J. M., Bundy, B. N., Wang, Y., Rayan, D. R., Trivedi, J. R., Sansone, V. A., et al. (2012). Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial. JAMA 308, 1357-1365.doi: 10.1001/jama.2012.12607
155. Steinmeyer, K., Ortland, C., and Jentsch, T. J. (1991a). Primary structure and functional expression of a developmentally regulated skeletal muscle chloride channel. Nature 354, 301-304.doi: 10.1038/354301a0
156. Steinmeyer, K., Klocke, R., Ortland, C., Gronemeier, M., Jockusch, H., Grunder, S., et al. (1991b). Inactivation of muscle chloride channel by transposon insertion in myotonic mice. Nature 354, 304-308.doi: 10.1038/354304a0
157. Stölting, G., Fischer, M., and Fahlke, C. (2014a). ClC-1 and ClC-2 form hetero-dimeric channels with novel protopore functions. Pflugers. Arch. 466, 2191-2204.doi: 10.1007/s00424-014-1490-6
158. Stölting, G., Fischer, M., and Fahlke, C. (2014b). CLC channel function and dysfunction in health and disease. Front. Physiol. 5:378.doi: 10.3389/fphys.2014.00378
159. Suominen, T., Schoser, B., Raheem, O., Auvinen, S., Walter, M., Krahe, R., et al. (2008). High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany. J. Neurol. 255, 1731-1736.doi: 10.1007/s00415-008-0010-z
160. Tricarico, D., Barbieri, M., and Camerino, D. C. (2000). Acetazolamide opens the muscular KCa2+ channel: a novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis. Ann. Neurol. 48, 304-312.doi: 10.1002/1531-8249(200009)48:3<304::AID-ANA4>3.0.CO;2-A
161. Tricarico, D., and Camerino, D. C. (1994). ATP-sensitive K+ channels of skeletal muscle fibers from young adult and aged rats: possible involvement of thiol-dependent redox mechanisms in the age-related modifications of their biophysical and pharmacological properties. Mol. Pharmacol. 46, 754-761.
162. Tricarico, D., Conte Camerino. D., Govoni, S., and Bryant, S. H. (1991). Modulation of rat skeletal muscle chloride channels by activators and inhibitors of protein kinase C. Pflugers. Arch. 418, 500-503.doi: 10.1007/BF00497778
163. Trivedi, J. R., Cannon, S. C., and Griggs, R. C. (2014). Nondystrophic myotonia: challenges and future directions. Exp. Neurol. 253, 28-30.doi: 10.1016/j.expneurol.2013.12.005
164. Tseng, P. Y., Bennetts, B., and Chen, T. Y. (2007). Cytoplasmic ATP inhibition of CLC-1 is enhanced by low pH. J. Gen. Physiol. 130, 217-221.doi: 10.1085/jgp.200709817
165. Tsujino, A., Kaibara, M., Hayashi, H., Eguchi, H., Nakayama, S., Sato, K., et al. (2011). A CLCN1 mutation in dominant myotonia congenita impairs the increment of chloride conductance during repetitive depolarization. Neurosci. Lett. 494, 155-160.doi: 10.1016/j.neulet.2011.03.002
166. Ulzi, G., Lecchi, M., Sansone, V., Redaelli, E., Corti, E., Saccomanno, D., et al. (2012). Myotonia congenita: novel mutations in CLCN1 gene and func-tional characterizations in Italian patients. J. Neurol. Sci. 318, 65-71.doi: 10.1016/j.jns.2012.03.024
167. Ursu, S. F., Alekov, A., Mao, N. H., and Jurkat-Rott, K. (2012). ClC1 chloride channel in myotonic dystrophy type 2 and ClC1 splicing in vitro. Acta Myol. 31, 144-153.
168. Waters, C. W., Varuzhanyan, G., Talmadge, R. J., and Voss, A. A. (2013). Huntington disease skeletal muscle is hyperexcitable owing to chloride and potassium channel dysfunction. Proc. Natl. Acad. Sci. U.S.A. 110, 9160-9165.doi: 10.1073/pnas.1220068110
169. Weinberger, S., Wojciechowski, D., Sternberg, D., Lehmann-Horn, F., Jurkat-Rott, K., Becher, T., et al. (2012). Disease-causing mutations C277R and C277Y modify gating of human ClC-1 chloride channels in myotonia congenita. J. Physiol. 590, 3449-3464.doi: 10.1113/jphysiol.2012.232785
170. Wheeler, T. M., Lueck, J. D., Swanson, M. S., Dirksen, R. T., and Thornton, C. A. (2007). Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J. Clin. Invest. 117, 3952-3957.doi: 10.1172/JCI33355
171. White, M. M., and Miller, C. (1979). A voltage-gated anion channel from the electric organ of Torpedo californica. J. Biol. Chem. 254, 10161-10166.
172. Wijnberg, I. D., Owczarek-Lipska, M., Sacchetto, R., Mascarello, F., Pascoli, F., Grünberg, W., et al. (2012). A missense mutation in the skeletal muscle chloride channel 1 (CLCN1) as candidate causal mutation for congenital myotonia in a New Forest pony. Neuromuscul. Disord. 22, 361-367.doi: 10.1016/j.nmd.2011.10.001
173. Wu, F. F., Ryan, A., Devaney, J., Warnstedt, M., Korade-Mirnics, Z., Poser, B., et al. (2002). Novel CLCN1 mutations with unique clinical and electrophysiological consequences. Brain 125, 2392-2407.doi: 10.1093/brain/awf246
174. Zhang, X. D., Tseng, P. Y., and Chen, T. Y. (2008). ATP inhibition of CLC-1 is controlled by oxidation and reduction. J. Gen. Physiol. 132, 421-428.doi: 10.1085/jgp.200810023
175. Zifarelli, G., and Pusch, M. (2007). CLC chloride channels and transporters: a biophysical and physiological perspective. Rev. Physiol. Biochem. Pharmacol. 158, 23-76.doi: 10.1007/112_2006_0605
176. Zifarelli, G., and Pusch, M. (2008). The muscle chloride channel ClC-1 is not directly regulated by intracellular ATP. J. Gen. Physiol. 131, 109-116.doi: 10.1085/jgp.200709899
177. Zifarelli, G., and Pusch, M. (2010). Relaxing messages from the sarcolemma. J. Gen. Physiol. 136, 593-596.doi: 10.1085/jgp.201010567